Erin Bastick, PharmD, RPh
Investigational drug appears beneficial in preventing migraines
Lilly's galcanezumab proves successful in three phase 3 migraine studies. Here are the findings.
Combination pack approved for breast cancer treatment
FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.
Top 5 specialty drug management issues
The 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.
How pharma reps impact physician prescribing
A new study led by The University of California researchers and published in JAMA reveals surprising findings.
New therapies show promise in treating diabetes
New therapies show promise in treating diabetes
New updates in insulin products, as well as non-pharma therapies are on the horizon for diabetes.
Cannabinoid-based drug pipeline shows promise
Cannabinoid-based drug pipeline shows promise
New treatment indications are under investigation for the use of cannabinoid-based drugs.
Cannabinoid-based drug pipeline grows: 4 ways to prepare
New treatment indications are under investigation for the use of cannabinoid-based drugs. Are you ready?
New diabetes medications help address linked diseases
Experts share updates on new diabetes medications, and provide an overview of what’s coming.
Four things health execs should know about the oncology pipeline
Four things health execs should know about the oncology pipeline
Here’s how you can recognize changes in the oncology pipeline and maximize value related to cancer care.
Statin prescribing varies in patients with diabetes
Wide variation exists in practice-level statin prescribing for patients with diabetes, according to a new study.

Poll

View Results